CAPS Capstone Therapeutics

NASDAQ
$0.19

Capstone Therapeutics (CAPS) Institutional Ownership

What the institutions did with CAPS last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers reporting
14
filed a 13F this quarter
Managers holding
9
+2 on the quarter
Buyers
7
7 opened new
Sellers
6
5 sold out entirely
Buyer share
53.9%
of managers who traded it
Breadth
+7.7
net buyers, as a share of those trading

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
GEODE CAPITAL MANAGEMENT, LLC 61.5K 29.5%
JANE STREET GROUP, LLC 46.8K 22.5%
StoneX Group Inc. 39.5K 19.0%
HRT FINANCIAL LP 22.0K 10.6%
GOLDMAN SACHS GROUP INC 15.9K 7.6%
NORTHERN TRUST CORP 11.0K 5.3%
Ground Swell Capital, LLC 10.4K 5.0%
BARCLAYS PLC 1.1K 0.5%
KERR FINANCIAL PLANNING Corp 75 0.0%

Largest changes

Manager Action Previous Current Change
JANE STREET GROUP, LLC New 0 46.8K +46.8K
StoneX Group Inc. New 0 39.5K +39.5K
XTX Topco Ltd Sold Out 23.2K 0 -23.2K
HRT FINANCIAL LP New 0 22.0K +22.0K
Virtu Financial LLC Sold Out 21.2K 0 -21.2K
GOLDMAN SACHS GROUP INC New 0 15.9K +15.9K
NORTHERN TRUST CORP New 0 11.0K +11.0K
Ground Swell Capital, LLC New 0 10.4K +10.4K
BARCLAYS PLC New 0 1.1K +1.1K
GEODE CAPITAL MANAGEMENT, LLC Reduced 61.7K 61.5K -205
UBS Group AG Sold Out 61 0 -61
CITIGROUP INC Sold Out 1 0 -1
MORGAN STANLEY Sold Out 1 0 -1

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.